Veristat News and Activities

Acquisition, funding and merger involving Veristat.

• Veristat has announced the acquisition of Certara  (posted on April 22 2026).

View the org chart displaying its 15 main executives

Most searched biographies at Veristat

• Kim Boericke, Chief Executive Officer
• Patrick Flanagan, Director
• Cindy Henderson, Chief Strategy Officer

Popular executive movements at Veristat

• Clint Wolfe has joined the company as Chief Human Resources Officer  (posted on June 15 2026).
• Demetrius Carter has joined the company as Senior Vice President, Regulatory Services  (posted on June 15 2026).
• Patrick Flanagan who was Chief Executive Officer, becomes Director  (posted on January 13 2026).

Click here to view some more movements at Veristat

Create your alert
to follow the executive moves at Veristat.

Veristat has 1,920 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Angelini Pharma has acquired Catalyst Pharmaceuticals (posted on July 13 2026).
• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).
• Novartis has announced the acquisition of Myricx Bio  (posted on July 6 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by Veristat

• Veristat Expands Biostatistics Leadership to Accelerate AI-Powered Drug Development in Complex Disease Areas
• Scaled complex patient narrative generation with consistent, high-quality outputs
• Rolling NDA and BLA Submissions: Accelerate Your Review Timeline
• Clear, Inclusive, Human: The Lay Language Shift Reshaping Clinical Communications
• Veristat Press Coverage
• Veristat Launches AI Biostatistics Platform: Cutting Clinical Trial Data Readout Time from 5 Weeks to 5 Days* Without Regulatory Risks
• After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS | Clene Inc.
• Veristat Acquires Certara's Regulatory and Medical Writing Business
• Veristat to Acquire Certara's Regulatory and Medical Writing Business
• Veristat Names Industry Veteran Kim McLean Boericke as 
New Chief Executive Officer
• View more press releases Close

Social media about Veristat

• Veristat on Wikipedia, Google News & Yahoo Finance
• Veristat on LinkedIn, X (Twitter) & YouTube